Schefter is a board certified (in both Canada and the US) radiation
oncologist. Dr. Schefter received her undergraduate engineering degree
from The Royal Military College of Canada (1985-1989) and her medical degree
from Queen's University in Kingston, Ontario, Canada (1990-1994).
Residency training in radiation oncology was completed at the Princess Margaret
Hospital in Toronto, Canada (1994-1999). She
completed a clinical fellowship at MD Anderson Cancer Center (MDACC,
1999-2000). She initiated a residency training program at the University
of Colorado Denver (UCD) and was the program director from 2003 through
2007. She is the director of the Stereotactic Body Radiation Therapy
(SBRT) program. She helped to develop the Selective
Internal Radiation Therapy (SIRT) for liver tumors using sir spheres and
theraspheres (which is now run through Interventional Radiology/IR).
She was the study chair for 2 national cooperative
group trials (RTOG cervical and ACOSOG esophageal) as well as the principle
investigator(PI) on numerous investigator initiated clinical trials (most
notable were 2 multi-center trials of SBRT for lung and liver metastases).
Dr. Schefter's main areas of expertise are gynecological (GYN) and
gastrointestinal (GI) cancers. She is the primary radiation
oncologist involved in the multidisciplinary GI tumor clinics
(esophageal, liver, pancreatic and CRC, separate clinics for each
subsite). She serves on several national committees. She has contributed
to more than 50 publications. She is an ad hoc reviewer for the Journal
of Clinical Oncology and the International Journal of Radiation Oncology
biology physics. She is an exercise enthusiast/competitor
and has completed Ironman several times, including podium finishes at the world
championships in Kona. Additionally to strike life balance, she became a
yoga instructor(Core Power Yoga 200 hour certification in 2009). She is a big
believer in exercise and yoga/meditation as it relates to quality of life and
stress coping strategies. Yoga has been shown to improve quality of life
for cancer patients.